|
|
???tair.name??? >
???browser.page.title.author???
|
"hung chih yang"???jsp.browse.items-by-author.description???
Showing items 36-60 of 96 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-07-18T03:51:40Z |
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection
|
Lee, Yu-Hsiang;Huang, Juin-Hua;Chang, Tzu-Hsuan;Hung-Chih Yang;Betty An-Ye Wu-Hsieh; Lee, Yu-Hsiang; Huang, Juin-Hua; Chang, Tzu-Hsuan; HUNG-CHIH YANG; BETTY AN-YE WU-HSIEH |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
Su, T.-H.;Yang, H.-C.;Tseng, T.-C.;Liou, J.-M.;Liu, C.-H.;Chen, C.-L.;Chen, P.-J.;Chen, D.-S.;Liu, C.-J.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu, C.-H.;Sun, H.-Y.;Liu, C.-J.;Sheng, W.-H.;Hsieh, S.-M.;Lo, Y.-C.;Liu, W.-C.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Tseng, T.-C.;Chen, P.-J.;Chen, D.-S.;Hung, C.-C.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
|
Papatheodoridis, G.V.;Manolakopoulos, S.;Su, T.-H.;Siakavellas, S.;Liu, C.-J.;Kourikou, A.;Yang, H.-C.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
Tung-Hung Su;Chun-Hsun Liao;Chen-Hua Liu;Kai-Wen Huang;Tai-Chung Tseng;Hung-Chih Yang;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:05:07Z |
A noninvasive diagnosis of hepatic fibrosis by BioFibroScoreR in chronic hepatitis C patients
|
HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; CHUN-MING HONG; DING-SHINN CHEN; JIA-HORNG KAO; Liu, C.-H.;Liu, C.-J.;Hong, C.-M.;Su, T.-H.;Yang, H.-C.;Chen, K.-M.;Huang, Y.-P.;Yeh, Y.-M.;Tien, H.-L.;Liu, Y.-C.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J. |
| 臺大學術典藏 |
2018-09-10T18:04:53Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
JIA-HORNG KAO; KAI-WEN HUANG; TUNG-HUNG SU; DING-SHINN CHEN; CHEN-HUA LIU; CHUN-JEN LIU; HUNG-CHIH YANG; Su, T.-H. and Shiau, C.-W. and Jao, P. and Yang, N.-J. and Tai, W.-T. and Liu, C.-J. and Tseng, T.-C. and Yang, H.-C. and Liu, C.-H. and Huang, K.-W. and Hu, T.-C. and Huang, Y.-J. and Wu, Y.-M. and Chen, L.-J. and Chen, P.-J. and Chen, D.-S. and Chen, K.-F. and Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng, T.-C. and Liu, C.-J. and Su, T.-H. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu, C.-H. and Liu, C.-J. and Su, T.-H. and Fang, Y.-J. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B
|
Yang, H.-C.;Shih, Y.-F.;Liu, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T18:03:46Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu, C.-H.;Chen, Y.-S.;Wang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; DING-SHINN CHEN; CHUN-MING HONG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:17Z |
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
|
Yang, Wan-Ting;Wu, Li-Wei;Tseng, Tai-Chung;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen;Kao, Jia-Horng; Wan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, Chi-Ling Chen, Hung-Chih Yang, Tung-Hung Su, Chia-Chi Wang, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu, Jia-Horng Kao; 劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳祈玲; HUNG-CHIH YANG; Yang, Wan-Ting; Wu, Li-Wei; CHUN-JEN LIU; Tseng, Tai-Chung; PEI-JER CHEN; Chen, Chi-Ling; CHEN-HUA LIU; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; Su, Tung-Hung; JIA-HORNG KAO; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
More viral mutants, less HBsAg clearance? One size may not fit all
|
Tseng, T.-C.;Yang, H.-C.;Kao, J.-H.; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:27:32Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H. and Liang, C.-C. and Liu, C.-J. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Liu, Chen-Hua; Liang, Cheng-Chao; CHUN-JEN LIU; PEI-JER CHEN; Liu, Chun-Jen; CHEN-HUA LIU; Lin, Chih-Lin; Su, Tung-Hung; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:26:55Z |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng, T.-C. and Liu, C.-J. and Chen, C.-L. and Yang, W.-T. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Chang, C-H.; Tseng, T. -C.; HUNG-CHIH YANG; CHUN-JEN LIU; Liu, C. -J.; PEI-JER CHEN; Chen, C. -L.; Yang, W. -T.; CHEN-HUA LIU; TUNG-HUNG SU; Yang, H. -C.; DING-SHINN CHEN; Su, T. -H.; Wang, C. -C.; JIA-HORNG KAO; Kuo, S. F. -T.; Liu, C. -H.; Chen, P. -J.; Chen, D. -S.; Kao, J. -H. |
Showing items 36-60 of 96 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
|
